We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

189 hedge funds and large institutions have $640M invested in Immunogen Inc in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 65 increasing their positions, 52 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more capital invested

Capital invested by funds: $468M → $640M (+$172M)

25% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 52

15% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 26

11% more call options, than puts

Call options by funds: $891K | Put options by funds: $803K

2% more funds holding

Funds holding: 185189 (+4)

Holders
189
Holders Change
+4
Holders Change %
+2.16%
% of All Funds
3.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
30
Increased
65
Reduced
52
Closed
26
Calls
$891K
Puts
$803K
Net Calls
+$88K
Net Calls Change
-$358K
Name Holding Trade Value Shares
Change
Change in
Stake
Los Angeles Capital Management
51
Los Angeles Capital Management
California
$1.01M +$20.9K +4,919 +2%
ERSOT
52
Employees Retirement System of Texas
Texas
$957K
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
$911K +$244K +57,377 +41%
PPA
54
Parametric Portfolio Associates
Washington
$879K +$153K +36,072 +23%
BC
55
Birchview Capital
Vermont
$874K
Principal Financial Group
56
Principal Financial Group
Iowa
$830K +$590K +138,791 +334%
FIM
57
Fernwood Investment Management
Massachusetts
$825K
Assenagon Asset Management
58
Assenagon Asset Management
Luxembourg
$811K +$750K +176,321 New
Acadian Asset Management
59
Acadian Asset Management
Massachusetts
$781K +$395K +92,843 +120%
Man Group
60
Man Group
United Kingdom
$777K -$200K -47,100 -22%
TCM
61
Tekla Capital Management
Massachusetts
$774K
William Blair & Company
62
William Blair & Company
Illinois
$774K +$10.3K +2,412 +1%
Citadel Advisors
63
Citadel Advisors
Florida
$765K -$2.1M -492,808 -75%
UBS AM
64
UBS AM
Illinois
$744K +$49.4K +11,611 +8%
Axa
65
Axa
France
$730K
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$724K +$115K +27,100 +21%
Skandinaviska Enskilda Banken (SEB)
67
Skandinaviska Enskilda Banken (SEB)
Sweden
$653K +$605K +142,200 New
Truist Financial
68
Truist Financial
North Carolina
$538K +$110K +25,793 +28%
SAMH
69
Shanda Asset Management Holdings
British Virgin Islands
$533K +$493K +115,875 New
Stifel Financial
70
Stifel Financial
Missouri
$530K -$10.5K -2,471 -2%
HighTower Advisors
71
HighTower Advisors
Illinois
$485K +$458K +107,646 New
AIG
72
American International Group
New York
$483K +$21.5K +5,049 +5%
TFCP
73
Twin Focus Capital Partners
Massachusetts
$479K
Rafferty Asset Management
74
Rafferty Asset Management
New York
$465K +$368K +86,546 +591%
HSA
75
Hussman Strategic Advisors
Maryland
$460K +$425K +100,000 New

IMGN Hedge Fund Activity: Q2 2020 in Review

189 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2020, worth a combined $640M — up 37% from $468M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new IMGN positions and 26 closed out — a net gain of 4 holders — while 65 added to existing stakes and 52 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $17.7M. The largest seller was Redmile Group, cutting an estimated $20.1M.

  • 189 institutional investors held Immunogen Inc (IMGN) as of Q2 2020, up from 185 in Q1 2020.
  • Funds reported $640M of Immunogen Inc stock for Q2 2020, up 37% quarter-over-quarter.
  • 30 funds opened new Immunogen Inc positions in Q2 2020 and 26 closed out, a net change of +4 holders.
  • The largest Immunogen Inc buyer in Q2 2020 was Wellington Management Group, an estimated $17.7M added.
  • The largest Immunogen Inc seller in Q2 2020 was Redmile Group, an estimated $20.1M sold.

Based on aggregated 13F filings for Q2 2020.